OPEN APP
Home / News / India /  India to initially introduce ZyCoV-D Covid vaccine in 7 states. Details here

India to initially introduce ZyCoV-D Covid vaccine in 7 states. Details here

Zydus Cadila will supply 1 crore doses of ZyCoV-D, the world's first Plasmid DNA COVID-19 vaccine, to the Government of India by December.Premium
Zydus Cadila will supply 1 crore doses of ZyCoV-D, the world's first Plasmid DNA COVID-19 vaccine, to the Government of India by December.

  • Pharmaceutical company Zydus Cadila will supply 1 crore doses of ZyCoV-D, the world's first Plasmid DNA Covid vaccine, to the Centre by this month
  • The Centre has already placed an initial order for one crore doses of the vaccine

Listen to this article

India will initially introduce of Cadila Healthcare's ZyCoV-D Covid-19 vaccine in seven states, including Maharashtra and West Bengal, news agency Reuters reported on Thursday.

Union Health Secretary Rajesh Bhushan, who reviewed the status and progress of the "Har Ghar Dastak" campaign with the health secretaries and National Health Mission (NHM) directors of the states and Union territories through a video-conference today, advised the seven states to identify the districts with a high number of first dose left out for the introduction of ZyCoV-D, a statement issued by the Union Health Ministry said.

The seven states are Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal.

The seven states have been asked to plan sessions based on the PharmaJet injector and identify vaccinators to be trained for using it for vaccination.

Pharmaceutical company Zydus Cadila will supply 1 crore doses of ZyCoV-D, the world's first Plasmid DNA Covid vaccine, to the Centre by this month. The Centre has already placed an initial order for one crore doses of the vaccine.

Earlier, the Centre had placed an order to supply one crore doses of ZyCoV-D at 265 per dose and the needle-free applicator being offered at 93 per dose, excluding GST.

Recently, the Central Drugs Standard Control Organisation (CDSCO) has approved ZyCoV-D for restricted use in emergency situation in the age group 12 years and above.

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus. It is also the first COVID-19 vaccine that is needle-free and administered using PharmaJet, a needle-free applicator to ensure painless intradermal vaccine delivery which also leads to a significant reduction in any kind of major side effects.

ZyCoV-D has shown good stability at temperatures of around 25 degrees for atleast three months. The thermostability of the vaccine will help in easy transportation and storage of the vaccine without any problems of fluctuations in temperature.

For prolonged use, a temperature of 2-8 degrees is sufficient. Also being a DNA plasmid vaccine, ZyCoV-D doesn't have any problem associated with vector-based immunity. The DNA Plasmid platform allows generating new constructs quickly to deal with mutations in the virus.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.
Close
Recommended For You
×
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout